February 26, 2018
The February episode of the Px Pulse podcast is up and brings you three perspectives on two recently launched major trials in HIV prevention: HPTN 084 testing a long-acting injectable antiretroviral called cabotegravir and HVTN 705/HPX 2008 testing a “mosaic” vaccine.
- What opportunities stand out in an advocate’s eyes as these trials enroll?
- What’s a mosaic vaccine?
- What’s the status of ethical standards at trial sites?
Explore these issues and more in this episode of Px Pulse, AVAC’s podcast on HIV prevention research today.
You’ll hear from Malawi’s veteran advocate Maureen Luba, Zimbabwe-based bioethicist Paul Ndebele and leading scientist Dan Barouch.
In a hurry? Select among the podcast highlights.